Soterix Medical Launches tsDCS for Companion Animals

Soterix Medical is pioneering new treatment options for companion animals with the launch of its transcutaneous spinal direct current stimulation (tsDCS) technology. This innovative approach targets domestic animals, such as dogs and cats, that have suffered severe spontaneous spinal cord injuries (SCI) and lack deep pain perception (DPP−), a condition previously challenging to treat.

Advancing Neurorehabilitation in Companion Animals

Animals with severe SCI face limited options for recovery, especially when they are DPP−, as traditional therapies often fall short of delivering meaningful improvements. Soterix Medical’s tsDCS technology is designed to integrate seamlessly into neurorehabilitation protocols, offering a non-invasive and effective option that stimulates the spinal cord to support neural recovery and functional improvements.

This cutting-edge therapy provides veterinarians and animal rehabilitation specialists with a valuable tool to address the complex needs of SCI-affected animals, enhancing their potential for recovery and improving quality of life.